Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation
December 15, 2022 08:00 ET
|
Aziyo Biologics
Follows recent equity financing, resulting in debt and equity gross proceeds of $15.2 million SILVER SPRING, Md., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a...
Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock
December 01, 2022 09:04 ET
|
Aziyo Biologics
SILVER SPRING, Md., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility...
Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock
November 30, 2022 16:08 ET
|
Aziyo Biologics
SILVER SPRING, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility...
Aziyo Biologics to Participate in Upcoming Investor Conferences
November 21, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a portfolio of regenerative products aimed at improving compatibility between...
Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
November 14, 2022 16:01 ET
|
Aziyo Biologics
Positive meeting with FDA provides clarity for CanGaroo® RM clearance SILVER SPRING, Md., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a...
Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022
November 07, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a regenerative medicine company with a portfolio of commercial therapies, today announced that it will...
Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors
October 24, 2022 08:00 ET
|
Aziyo Biologics
SILVER SPRING, Md., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a regenerative medicine company with a portfolio of commercial therapies, today announced the appointment...
Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets
October 11, 2022 16:35 ET
|
Aziyo Biologics
SILVER SPRING, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biological device company with a portfolio of commercial products across four distinct businesses, today...
Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer
August 26, 2022 09:00 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company announced today that Michelle LeRoux Williams, Ph.D. has...
Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 17, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced the company will present at the upcoming...